社会人口学特征与家长HPV疫苗犹豫对五州HPV疫苗接种覆盖率的影响
研究分析了2021年7月美国阿肯色、密西西比、密苏里、田纳西和南伊利诺伊州926名9-17岁儿童家长的在线调查,发现家长疫苗犹豫者子女接种HPV疫苗的可能性显著低于不犹豫者(AOR: 0.17,95%CI: 0.11-0.27),男孩接种可能性低于女孩(AOR: 0.70,95%CI: 0.50-0.97),年龄较大儿童及接种过脑膜炎球菌结合疫苗或近期流感疫苗者接种可能性更高。
要点
- 家长HPV疫苗犹豫者子女接种任何剂次HPV疫苗的可能性显著低于不犹豫者(AOR: 0.17,95%CI: 0.11-0.27)。
- 男孩开始HPV疫苗系列接种的可能性低于女孩(AOR: 0.70,95%CI: 0.50-0.97)。
- 13-17岁较9-12岁儿童、接种过脑膜炎球菌结合疫苗或近期流感疫苗者接种HPV疫苗可能性更高。
核心结论
- 目标州青少年HPV疫苗接种覆盖率仍较低,儿童年龄、性别和家长疫苗犹豫与HPV疫苗接种可能性显著相关,为低接种率地区家长针对性干预提供机会,并强调制定实施策略解决家长HPV疫苗犹豫以提升美国接种率的重要性。
研究设计与样本
- 2021年7月对阿肯色、密西西比、密苏里、田纳西和南伊利诺伊州926名9-17岁儿童家长进行在线Qualtrics调查,采用多因素logistic回归分析社会人口学特征和HPV疫苗犹豫与接种覆盖率的关联。
主要发现
- 家长中78%为女性,76%为非西班牙裔白人,61.9%居住在农村地区,22%被归类为HPV疫苗犹豫,42%已为9-17岁最年长子女接种HPV疫苗;疫苗犹豫家长子女接种任何剂次HPV疫苗的可能性低于不犹豫家长子女(AOR: 0.17,95%CI: 0.11-0.27);男孩开始HPV疫苗系列接种可能性低于女孩(AOR: 0.70,95%CI: 0.50-0.97);13-17岁较9-12岁儿童接种任何剂次可能性更高(AOR: 6.01,95%CI: 3.98-9.08);接种过脑膜炎球菌结合疫苗者更高(AOR: 2.24,95%CI: 1.27-3.95);接种过近期季节性流感疫苗者更高(AOR: 2.41,95%CI: 1.73-3.36)。
关键数值与推荐
- 疫苗犹豫家长子女接种任何剂次HPV疫苗的AOR为0.17(95%CI: 0.11-0.27),低于不犹豫家长子女。
- 男孩开始HPV疫苗系列接种的AOR为0.70(95%CI: 0.50-0.97),低于女孩。
- 13-17岁较9-12岁儿童接种任何剂次HPV疫苗的AOR为6.01(95%CI: 3.98-9.08)。
- 接种过脑膜炎球菌结合疫苗者接种任何剂次HPV疫苗的AOR为2.24(95%CI: 1.27-3.95)。
- 接种过近期季节性流感疫苗者接种任何剂次HPV疫苗的AOR为2.41(95%CI: 1.73-3.36)。
临床怎么用
- 作者认为这些发现为低疫苗接种率地区的家长针对性干预提供了机会。
- 作者强调制定和实施策略解决家长HPV疫苗犹豫以提升美国接种率的重要性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the United States (US), half of new human papillomavirus (HPV) infections occur among young people aged 15-24 years. Despite the effectiveness of HPV vaccination in protecting against HPV-associated cancers, its coverage among adolescents remains suboptimal. This study examined the association of sociodemographic characteristics and HPV vaccination hesitancy with HPV vaccination coverage in five US states with disproportionately low adolescent coverage rates compared to the national average. METHODS: Responses to an online Qualtrics survey from 926 parents of children aged 9-17 years in Arkansas, Mississippi, Missouri, Tennessee, and Southern Illinois in July 2021 were analyzed using multivariate logistic regression to estimate the association of sociodemographic characteristics and HPV vaccination hesitancy with HPV vaccination coverage. RESULTS: Of the parents, 78 % were female, 76 % were non-Hispanic White, 61.9 % lived in rural areas, 22 % were classified as HPV vaccine hesitant, and 42 % had vaccinated their oldest child between the ages of 9-17 years against HPV. Children of vaccine hesitant parents were less likely to have received any doses of the HPV vaccine than children of non-vaccine hesitant parents (AOR: 0.17, 95 % CI:0.11-0.27). Male children were less likely to have initiated the HPV vaccine series than female children (AOR: 0.70, 95 % CI:0.50-0.97). Older children (13-17 vs 9-12 years), receiving the meningococcal conjugate or most recent seasonal influenza vaccine were all associated with higher likelihoods of receiving any doses of the HPV vaccine (AOR: 6.01, 95 % CI:3.98-9.08; AOR: 2.24, 95 % CI:1.27-3.95; AOR: 2.41, 95 % CI:1.73-3.36, respectively). CONCLUSIONS: Adolescent HPV vaccination coverage remains low in our targeted states. Children's age, sex, and parental vaccine hesitancy were significantly associated with likelihood of HPV vaccination. These findings offer the opportunity for targeted interventions among parents in regions with low vaccine uptake and underscore the importance of developing and implementing strategies to address parental HPV vaccination hesitancy to improve uptake in the US.
引用
- Shato T, Humble S, Anandarajah A, et al. Influences of sociodemographic characteristics and parental HPV vaccination hesitancy on HPV vaccination coverage in five US states. Vaccine. 2023. PMID: 37198022. doi:10.1016/j.vaccine.2023.04.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。